Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Which anticoagulants?].

J C Wautrecht1

  • 1Service de Pathologie Vasculaire, Hôpital Erasme, U.L.B.

Revue Medicale De Bruxelles
|November 9, 2002
PubMed
Summary
This summary is machine-generated.

Low molecular weight heparins (LMWHs) and vitamin K antagonists are key anticoagulants. LMWHs are suitable for pregnancy, while vitamin K antagonists have contraindications during gestation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Screening Program of Abdominal Aortic Aneurysm.

Angiology·2019
Same author

Requirements for angiology/vascular medicine.

International angiology : a journal of the International Union of Angiology·2013
Same author

[Thrombocytosis in patients treated with low-molecular-weight heparin: more common than imagined?].

Journal des maladies vasculaires·2010
Same author

[New developments in antithrombotic care].

Revue medicale de Bruxelles·2009
Same author

Spontaneous renal artery dissection in an otherwise healthy male.

Acta chirurgica Belgica·2007
Same author

Accuracy and safety of pretest probability assessment of deep vein thrombosis by physicians in training using the explicit Wells clinical model.

Journal of thrombosis and haemostasis : JTH·2006
Same journal

[Breast cancer screening : a tool for informed decision making].

Revue medicale de Bruxelles·2018
Same journal

[Breast cancer screening : present situation and prospects].

Revue medicale de Bruxelles·2018
Same journal

[Guidelines in medical imaging : objectives, limits and radiation protection].

Revue medicale de Bruxelles·2018
Same journal

[How to avoid overmedicalization of the elderly patient ?]

Revue medicale de Bruxelles·2018
Same journal

[Ethical, pedagogical, socio-political and anthropological implications of quaternary prevention].

Revue medicale de Bruxelles·2018
Same journal

[New strategies in specific care for benign prostatic hypertrophy in older men].

Revue medicale de Bruxelles·2018
See all related articles

Area of Science:

  • Pharmacology
  • Internal Medicine
  • Hematology

Context:

  • Anticoagulant therapy is crucial for managing thromboembolic disorders.
  • Low molecular weight heparins (LMWHs) and vitamin K antagonists are primary anticoagulant agents in clinical practice.

Purpose:

  • To outline the clinical applications, administration, and contraindications of LMWHs and vitamin K antagonists.
  • To differentiate the use of these anticoagulants in specific patient populations, including pregnant and breastfeeding individuals.

Summary:

  • LMWHs are administered subcutaneously, weight-adjusted for therapeutic indications, and are renally cleared, making them contraindicated in renal insufficiency. They are indicated for venous thromboembolism (VTE) prevention and treatment and are safe during pregnancy and breastfeeding.
  • Vitamin K antagonists are the preferred oral anticoagulants for long-term management. They are contraindicated in pregnancy due to embryopathy risk (6-12 weeks gestation) but can be used with precautions during breastfeeding. Indications include long-term VTE treatment, prevention of thromboembolic events in antiphospholipid syndrome, and prophylaxis in patients with heart valves, rheumatic mitral valve disease, atrial fibrillation, and acute myocardial infarction.

Related Experiment Videos

Impact:

  • Provides essential information for clinicians regarding the safe and effective use of common anticoagulants.
  • Highlights critical differences in indications and contraindications, particularly for vulnerable populations like pregnant women.